1Deguchi T,Yasuda M,Nakano M,et al.Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones[].Journal of Clinical Microbiology.1996
2Deguchi T,Yasuda M,Asano M,et al.DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae[].Antimicrobial Agents and Chemotherapy.1995
4Gerbase AC, Rowley Jr, Heymann DH, et al. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect, 1998, 74 Suppl 1:S12-S16.
5Low N, Daker-White G, Barlow D, et al.Gonorrhoea in inner London: results of a cross sectional study. BMJ, 1997, 314:1719-1723.
6Roche P, Spencer J, Lin M, et al. Australia's notifiable diseases status, 1999: annual report of the National Notif'mble Diseases Surveillance System. Commun Dis Intell,2001, 25:190-245.
7Martin IM, lson CA. Rise in gonorrhoea in London, UK. London Gonococcai Working Group. Lancet, 2000, 355:623.
8Donovan B, Bodsworth N J, Rohrsheim R,et al. Increasing gonorrhoea reports--not only in London. Lancet, 2000, 355:1908.
9Waugh MA. Task force for the urgent response to the epidemics of sexually transmitted diseases in eastern Europe and central Asia. Sex Transm Infect, 1999, 75:72-73.
10Cohen MS, Hoffman IF, Royce RA, et al.Reduction of concentration of HIV-1 in semen after treatment Of urethritis: implications for prevenfiofi of sexual transmission of HIV-1. MDSCAP Malawi Research Group. Lancet, 1997, 349:1868-1873.
